Background: Basic fibroblast growth factor (FGF-S), a potent angiogenic peptide, is known to be present in gonadotropes of the anterior pituitary parenchyma of rats and mice, and has been isolated from endothelial cells of many organs. Its localization within endothelial cells has not been determine
Effects of basic fibroblast growth factor on endothelial cells under conditions of simulated microgravity
✍ Scribed by Claudia Ulbrich; Kriss Westphal; Sarah Baatout; Markus Wehland; Johann Bauer; Burkhard Flick; Manfred Infanger; Reinhold Kreutz; Sonia Vadrucci; Marcel Egli; Augusto Cogoli; Hanane Derradji; Jessica Pietsch; Martin Paul; Daniela Grimm
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 812 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Fibroblast growth factors interact with appropriate endothelial cell (EC) surface receptors and initiate intracellular signal cascades, which participate in modulating blood vessel growth. EC, upon exposure to basic fibroblast growth factors (bFGFs) undergo profound functional alterations, which depend on their actual sensitivity and involve gene expression and de novo protein synthesis. We investigated the effects of bFGF on signaling pathways of EA.hy926 cells in different environments. EC were cultured under normal gravity (1 g) and simulated microgravity (µg) using a three‐dimensional (3D) clinostat. Microgravity induced early and late apoptosis, extracellular matrix proteins, endothelin‐1 (ET‐1) and TGF‐β~1~ expression. Microgravity reduced eNOS mRNA within 24 h. Moreover, a six‐ to eightfold higher amount of IL‐6 and IL‐8 was secreted within 24 h µg. In addition, microgravity induced a duplication of NF‐kappaB p50, while p65 was quadrupled. At 1 g, bFGF application (4 h) reduced ET‐1, TGF‐β~1~ and eNOS gene expression. After 24 h, bFGF enhanced fibronectin, VEGF, Flk‐1, Flt‐1, the release of IL‐6, IL‐8, and TGF‐β~1~. Furthermore, bFGF promoted apoptosis, reduced NFkB p50, but enhanced NFkB p65. After 4 h µg, bFGF decreased TGF‐β~1~, eNOS, and ET‐1 gene expression. After 24 h µg, bFGF elevated fibronectin, Flk‐1 and Flt‐1 protein, and reduced IL‐6 and IL‐8 compared with vehicle treated µg cultures. In µg, bFGF enhanced NF‐KappaB p50 by 50%, Bax by 25% and attenuated p65, activation of caspase‐3 and annexin V‐positive cells. bFGF differently changes intracellular signals in ECs depending whether it is applied under microgravity or normal gravity conditions. In microgravity, bFGF contributes to protect the EC from apoptosis. J. Cell. Biochem. 104: 1324–1341, 2008. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
The growth of capillary endothelial cells (BCE) is an important regulatory step in the formation of capillary blood vessels. In vivo, the proliferation of these cells is stringently controlled. In vitro they can be stimulated by polypeptide growth factors, such as acidic fibroblast growth factor (aF
The effect5 of sulfated polysaccharides on the growth and chemotdxis of endothel i d cells promoted by basic fibroblast growth factor (brGF), a heparin-binding growth factor, and epidermal growth factor (EGF), a non-heparin-binding growth factor, were examined. The binding abilities of these two gro
To study the relationship between androgen metabolism and the pathogenesis of benign prostatic hypertrophy, we purified a growth factor from benign hyperplastic tissue of human prostates and assayed the proliferative responses of human fetal prostatic fibroblasts to the purified growth factor (hPGF)